The FDA announced on 2019-11-25 that AuroMedics Pharma LLC voluntarily recalled Vancomycin Hydrochloride for Injection due to discoloration after reconstitution. The recall affects 275,060 vials distributed nationwide.
How to tell if you have it
- Brand: AuroMedics Pharma
- Product: Vancomycin Hydrochloride for Injection, USP, 1 g* per vial
- Packaging: 10-count vials per carton
- NDC: 55150-204-20
- Lot codes: CVM180003 (Exp 04/2020), CVM180004 (Exp 04/2020), CVM180008 (Exp 07/2020), CVM180009, CVM180010, CVM180011, CVM180012 (Exp 09/2020)
- Distribution: Nationwide in the USA
The hazard
The product complaints involve discoloration after reconstitution of vials. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show AuroMedics Pharma LLC has 22 other recalls on record since 2017-12-04. Other recent recalls include an AuroMedics Fondaparinux Injection recall for subpotent drug risk (2022-09-30), an AuroMedics Tranexamic Acid Injection recall for metal particulate hazard (2022-09-26), and an AuroMedics Acyclovir Injection recall for particulate matter hazard (2022-09-26). Other recent recalls of similar products include a Baxter Vancomycin Injection recall for CGMP deviations in single-dose containers (2026-08-06), another Baxter Vancomycin Injection recall for CGMP deviations risk (2026-08-06), and a Fagron Vancomycin Injection recall for blue break-off-part risk (2026-03-20).